Innovation in Heart Failure Treatment: Life Expectancy, Disability, and Health Disparities.

Objectives: The goal of this study was to illustrate the potential benefit of effective congestive heart failure (CHF) treatment in terms of improved health, greater social value, and reduced health disparities between black and white subpopulations.

Background: CHF affects 5.7 million Americans, costing $32 billion annually in treatment expenditures and lost productivity.